ElizabethMGoreMD

Radiation Oncology • Milwaukee, WI

Associate Professor, Radiation Oncology, Medical College of Wisconsin

Join to view full profile

Dr. Gore is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gore's full profile

Already have an account?

Office
9200 W Wisconsin Ave
Department Of Radiation Oncology
Milwaukee, WI 53226
Phone+1 414-805-4400

Fax+1 414-805-4369

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Radiation Oncology, 1990 - 1994
Medical College of WisconsinClass of 1990

Certifications & Licensure

WI State Medical License 1991 - 2025
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
Super Doctor SuperDoctors.com

Clinical Trials

Celecoxib and Radiation Therapy in Treating Patients With Locally Advanced Non-Small Cell Lung Cancer Start of enrollment: 2002 Jul 01
Completed
Phase 1, Phase 2
Radiation Therapy in Preventing Central Nervous System (CNS) Metastases in Patients With Non-Small Cell Lung Cancer Start of enrollment: 2002 Sep 01
Completed
Phase 3
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery Start of enrollment: 2007 Dec 01
Completed
Phase 2
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Start of enrollment: 2008 Mar 01
Completed
Phase 2
Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Start of enrollment: 2008 Mar 01
Active, not recruiting
Phase 3
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer Start of enrollment: 2009 Feb 01
Completed
Phase 1, Phase 2
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer Start of enrollment: 2010 Mar 31
Active, not recruiting
Phase 3
Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer Start of enrollment: 2011 Feb 01
Completed
Phase 2
Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer Start of enrollment: 2010 Mar 01
Completed
Phase 2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Start of enrollment: 2011 Feb 14
Completed
Phase 3
Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Surgery With or Without Internal Radiation Therapy Compared With Stereotactic Body Radiation Therapy in Treating Patients With High-Risk Stage I Non-Small Cell Lung Cancer Start of enrollment: 2011 May 01
Terminated
Phase 3
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer Start of enrollment: 2012 Feb 22
Active, not recruiting
Phase 2
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer
ACTIVE_NOT_RECRUITING
PHASE3
Join now to see all

Publications & Presentations

PubMed

Radiobiologically equivalent deformable dose mapping for re-irradiation planning: Implementation, robustness, and dosimetric benefits.
Juan A García-Alvarez, Eric Paulson, Kristofer Kainz, Lindsay Puckett, Monica E Shukla
Radiotherapy and Oncology. 2025-04-01
5-hydroxymethylcytosine sequencing of plasma cell-free DNA identifies epigenomic features in prostate cancer patients receiving androgen deprivation therapies.
Qianxia Li, Chiang-Ching Huang, Shane Huang, Yijun Tian, Jinyong Huang
Communications Medicine. 2025-03-04
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Corre...
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, Elai Davicioni, Alejandro Berlin
International Journal of Radiation Oncology, Biology, Physics. 2024-12-01

Journal Articles

Current Predictive Indices and Nomograms to Enable Personalization of Radiation Therapy for Patients with Secondary Malignant Neoplasms of the Central Nervous System: ...
Elizabeth Gore, Joseph Bovi, Joseph Bovi, Christopher Schultz, Christopher Schultz, Elizabeth Gore, Neurosurgery

Press Mentions

Effect of Androgen Deprivation on Long-Term Outcomes of Intermediate-Risk Prostate Cancer Stratified as Favorable or UnfavorableSeptember 1st, 2020
Health Care at Milwaukee VA Draws More Acclaim, CriticismMarch 10th, 2020
Brain Radiation After Lung Cancer Treatment Reduces Risk of Cancer SpreadingSeptember 6th, 2012

Grant Support

MCW NCTN Lead Academic Participating SiteMEDICAL COLLEGE OF WISCONSIN2019–2025

Committees

Member, Definitive and Adjuvant Radiotherapy in Locally Advanced Non-small Cell Lung Cancer Guideline Panel, American Society for Radiation Oncology 2015 - Present